Warning: Undefined variable $zfal in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Deprecated: str_replace(): Passing null to parameter #3 ($subject) of type array|string is deprecated in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 525
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 530
 free
Warning: Undefined variable $sterm in C:\Inetpub\vhosts\kidney.de\httpdocs\mlpefetch.php on line 531
 free
 free
 
English Wikipedia
Nephropedia Template TP (
Twit Text
DeepDyve
Pubget Overpricing |  
lüll
Nitric oxide synthases in heart failure Carnicer R; Crabtree MJ; Sivakumaran V; Casadei B; Kass DAAntioxid Redox Signal 2013[Mar]; 18 (9): 1078-99SIGNIFICANCE: The regulation of myocardial function by constitutive nitric oxide synthases (NOS) is important for the maintenance of myocardial Ca(2+) homeostasis, relaxation and distensibility, and protection from arrhythmia and abnormal stress stimuli. However, sustained insults such as diabetes, hypertension, hemodynamic overload, and atrial fibrillation lead to dysfunctional NOS activity with superoxide produced instead of NO and worse pathophysiology. RECENT ADVANCES: Major strides in understanding the role of normal and abnormal constitutive NOS in the heart have revealed molecular targets by which NO modulates myocyte function and morphology, the role and nature of post-translational modifications of NOS, and factors controlling nitroso-redox balance. Localized and differential signaling from NOS1 (neuronal) versus NOS3 (endothelial) isoforms are being identified, as are methods to restore NOS function in heart disease. CRITICAL ISSUES: Abnormal NOS signaling plays a key role in many cardiac disorders, while targeted modulation may potentially reverse this pathogenic source of oxidative stress. FUTURE DIRECTIONS: Improvements in the clinical translation of potent modulators of NOS function/dysfunction may ultimately provide a powerful new treatment for many hearts diseases that are fueled by nitroso-redox imbalance.|Animals[MESH]|Arginase/antagonists & inhibitors/metabolism[MESH]|Autocrine Communication[MESH]|Biopterins/analogs & derivatives/physiology[MESH]|Calcium Signaling[MESH]|Cyclic GMP/physiology[MESH]|Diabetes Mellitus/metabolism[MESH]|Disease Progression[MESH]|Enzyme Activation[MESH]|Enzyme Induction[MESH]|Heart Diseases/complications/enzymology/physiopathology[MESH]|Heart Failure/*enzymology[MESH]|Humans[MESH]|Hypertension/complications/metabolism[MESH]|Myocardium/metabolism[MESH]|Myocytes, Cardiac/metabolism[MESH]|Nitric Oxide Synthase/chemistry/*physiology[MESH]|Nitric Oxide/physiology[MESH]|Paracrine Communication[MESH]|Protein Processing, Post-Translational[MESH]|Protein Structure, Tertiary[MESH]|Protein Transport[MESH]|Signal Transduction/physiology[MESH]|Superoxides/metabolism[MESH] |
